Multipart drug delivery system
US6322815A · kind A · utility
Inventors
Key dates
| Filing date | Jul 22, 1994 |
| Grant date | Nov 27, 2001 |
| Priority date | — |
| Expiry date | Jul 22, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/61
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Polymeric drug conjugates in controlled release matrices are provided which allow sustained concentrations of therapeutic agents within a treated area for a prolonged period. The polymeric drug conjugates hydrolytically degrade in the extracellular space in a controlled, pre-specified pattern, releasing active drug. The conjugates diffuse within the tissue reaching a greater distance from the matrix than free drug would, because of their reduced rate of clearance from the tissue via the capillary system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.